In a report released today, Reni Benjamin from JMP Securities reiterated a Hold rating on Instil Bio (TIL – Research Report). The ...
JMP Securities analyst Andrew Boone raised the firm’s price target on Shopify (SHOP) to $120 from $80 and keeps an Outperform rating on ...
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “market outperform” rating reissued by equities researchers at JMP Securities in a report issued on Tuesday,Benzinga reports. They ...
There's a tropical system brewing in the Caribbean, which could develop into a hurricane. Floridians are urged to monitor ...
William Blair restated an “outperform” rating on shares of Incyte in a report on Monday, September 9th. JMP Securities ...
Maintaining their stance, an analyst from JMP Securities continues to hold a Market Outperform rating for ServiceNow, ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 86.85% ...
This was an agreement that was made back in February 2023 with Evercore Group, JMP Securities and B. Riley Securities to ...
Earlier, on September 27, 2022, JMP Securities had initiated the stock to Mkt Outperform, setting a price target of $22. Goldman also resumed Buy rating with a price target of $38. Additionally, ...
JMP Securities analyst Jason Butler downgraded Syros Pharmaceuticals (SYRS) to Market Perform from Outperform without a price target The firm cites the “disappointing results” from the Phase 3 ...